NCT04459013

Brief Summary

In recent decades, the field of public health has become increasingly interested in endocrine disruptors, and their effects on humans. Indeed, various scientific studies have highlighted an evolution in the frequency of pathologies due to these substances, affecting in particular the reproductive organs. Many concerns are expressed about the impact of these substances, present in the environment or in consumer products, on the hormonal system. Effects have been observed in animals in experimental studies, but the question of extrapolating these results to humans arises, especially for exposures at low doses. In orthodontics, the composite is the material of choice mainly for bonding fasteners, then bonding a compression wire. These composite materials contain many monomers. The polemics launched on Bisphenol A and the questions of our patients on the nature and toxicity of dental products oblige us to reflect on their harmfulness after their placement in the oral cavity. Many questions arise today about dental composites and their participation in the release of endocrine disruptors. Indeed, Bisphenol A is used in the manufacturing process of the monomers of orthodontic composites, as precursors of Bis-GMA and Bis-DMA. The objective of this study is to search for the presence of BPA, TEGDMA, BisGMA, BisDMA and UDMA monomers, and to carry out the samples and their analysis at different clinical times (at T0, after the removal of orthodontic attachments, after the placement of the compression, one hour later, one week later, one month later and 6 months later) and the comparison of this quantification to that without orthodontic restraint. Studies have been performed in vitro, but very little in vivo. In addition, these studies are only carried out on release at the time of installation, but few are interested in the continuation of the phenomenon over time and the deterioration of the composite. Although the short-term toxicity of BPA is low, its dangerousness lies in its potential endocrine disrupting effect and which can induce long-term chronic toxicity. Compounds such as TEGDMA, BisGMA, BisDMA and UDMA differ greatly in their volatility due to their different chemical structures as well as in their stability in saliva; Many methods have been developed to study each monomer individually or to study them simultaneously using different analytical techniques to determine their presence and to quantify them after their release from dental products. The analysis of the samples is carried out by liquid chromatography (HPLC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2020

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

June 17, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2020

Completed
Last Updated

November 21, 2023

Status Verified

November 1, 2023

Enrollment Period

5 months

First QC Date

June 17, 2020

Last Update Submit

November 20, 2023

Conditions

Keywords

Bisphenol AtoxicityCompositeorthodontic retainersreleaseendocrine disruptors

Outcome Measures

Primary Outcomes (1)

  • Changement of quantity of the Bisphenol A

    The main objective of this research is the quantification of the Bisphenol A monomer released during the placement of a mandibular orthodontic compression in order to raise awareness among professionals or without orthodontic restraint..

    before any medical procedure, and regularly after the medical procedure

Secondary Outcomes (2)

  • Changement of quantity of the release of TEGDMA monomers; UDMA; BisGMA and BisDMA

    before any medical procedure, and regularly after the medical procedure

  • Changement of those quantities in patients with mandibular orthodontic restraints with patients without restraints

    before any medical procedure, and regularly after the medical procedure

Study Arms (1)

Patient of the orthodontic consultation

Other: Salivary samples

Interventions

The salivary samples will be collected at 5 defined times

Patient of the orthodontic consultation

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient of the orthodontic consultation consultant in the dentistry department of the Pitié Salpêtrière hospital,

You may qualify if:

  • Patient of the orthodontic consultation consultant in the dentistry department of the Pitié Salpêtrière hospital,
  • Information and collection of the non-opposition of the adult patient or representatives of the parental authority for minors
  • Good dental hygiene at the discretion of the investigator
  • Patient agreeing to be followed for 6 months
  • Good written and oral comprehension of the French language
  • case-specific:
  • Age between 10 and 70 years inclusive,
  • Patients undergoing orthodontic treatment (multi-attachment device) with planned debagging and requiring compression with bonded mandibular wire from canine to canine, and maxillary groove
  • Specific to witnesses:
  • Age between 18 and 70 inclusive
  • Patients undergoing orthodontic treatment (multi-attachment appliance) with planned debridement without the need for a retainer

You may not qualify if:

  • Under tutorship or curatorship
  • Opposition of the minor patient
  • Gingival inflammation
  • Patients requiring maxillary bonded restraint
  • Composite restoration in the mouth
  • Carious lesions
  • Smokers
  • Patients with chronic pathologies and / or under medication
  • Chronic exposure to Bisphenol A.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service Odontology, Hôpital Pitié-Salpêtrière

Paris, Île-de-France Region, 75013, France

Location

MeSH Terms

Conditions

Dent Disease

Condition Hierarchy (Ancestors)

Renal Tubular Transport, Inborn ErrorsKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2020

First Posted

July 7, 2020

Study Start

June 3, 2020

Primary Completion

October 30, 2020

Study Completion

December 16, 2020

Last Updated

November 21, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations